The agency reported actions against a biotech company and two large stem cell clinics over unapproved treatments, a move it said was necessary to make way for speedier approval of legitimate therapies.
from NYT > Health http://ift.tt/2wcyO8w
via health&fitness
Aucun commentaire:
Enregistrer un commentaire